Menu Close

Despite unprecedented breakthroughs made by modern science during recent years, a dramatically wide gap remains between understanding biological processes in the human body and practical instruments used by conventional doctors. Translational medicine is an “Esperanto” accepted by both medical and research communities to combine efforts and facilitate advanced scientific solutions for application into real life in a smart and productive way.  

The IPTM, established in 2014 by Dr. Igor Koman at AU, aims to enrich translational technologies by evoking the philosophy of personalization in order to find exclusive solutions for individual patients’ unmet clinical needs. 

Our team, consisting of both biological scientists and medical professionals, sees the patient as a complete holistic system where each parameter is linked to all the others, has equal value and may influence the final outcome. 

By declaring a patient centered approach, we develop two parallel but tightly coordinating arms of our research activities: identification of unique individual therapeutic targets and an intensive search for safe and highly effective agents acting towards those targets.

Click here to learn about Personalized Oncology and
Drug Development at IPTM.

Our Partners